117 results
424B5
TCON
TRACON Pharmaceuticals Inc
12 Apr 24
Prospectus supplement for primary offering
4:36pm
and Russia, the war between Israel and Hamas and the related risk of a larger regional conflict, recent and potential future disruptions in access to bank
8-K
EX-99.1
TCON
TRACON Pharmaceuticals Inc
5 Mar 24
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
4:08pm
, compared to a net loss of $7.0 million for the fourth quarter of 2022.
Conference Call Details
To access the call by phone, please register using
8-K
EX-99.1
li0v4 jop9
9 Nov 23
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
6zfu8u8pd66f9bf ez5r
14 Aug 23
TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:12pm
424B3
85pfg6qckcd5
31 May 23
Prospectus supplement
4:21pm
8-K
EX-99.1
q9q2b
10 May 23
TRACON Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:07pm
8-K
ytdufwn coxolq71c
20 Apr 23
Entry into a Material Definitive Agreement
4:47pm
8-K
wn5jut3rwg7 w3fqrh
6 Apr 23
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-99.1
syz4vsikqr78hqn
14 Nov 22
TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:01pm